IFNA2 and breast cancer: Our results show that the addition of low doses of IFN-α substantially enhanced the expression of CD40high, CD86high, HLA class IIhigh in DCs generated from adherent cultures of monocytes obtained from blood and lymph nodes of patients with operable breast cancer.